News of Note—NIH Zika vaccine trial, VBI Vaccines and more
admin 21st August 2018 Uncategorised 0Here is some other vaccine news of note for the week. More: News of Note—NIH Zika vaccine trial, VBI Vaccines and more Source: fierce
read more
Here is some other vaccine news of note for the week. More: News of Note—NIH Zika vaccine trial, VBI Vaccines and more Source: fierce
read moreThe FDA took steps Tuesday to mitigate the shortage of EpiPens by allowing some expired devices for treating life-threatening allergic reactions to remain on the market. More: FDA fights EpiPen shortage by extending expiration date for some devices Source: fierce
read moreMore big-name suitors are jumping into the mix for GlaxoSmithKline’s Indian consumer health unit. After earlier reports that Danone, Nestle and others were on the verge of a bidding war, Kellogg and Reckitt Benckiser are said to be suiting up.
read moreMylan and Pfizer failed to dispatch a lawsuit that accuses the two companies of a massive, far-ranging scheme to pump up sales of the epinephrine injector EpiPen, which Pfizer manufactures for Mylan to sell. More: EpiPen partners Mylan, Pfizer have
read moreAfter Merck’s Keytruda-chemo combo demonstrated a mammoth survival advantage back in April, industry watchers fully expected it to win a full approval in previously untreated non-small cell lung cancer. What they may not have expected was how quickly it would
read moreThe World Health Organisation is calling on countries to implement broad measures to stop the spread of measles after the number of cases reached a record high in the region. More: Measles cases in Europe hit record high Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals